Racial and ethnic minorities appear to gain fewer mental health benefits from psychedelic use compared to non-Hispanic Whites, and in some cases psychedelic use is linked to worse mental health among Black and Asian populations. Analyzing data from the National Survey of Drug Use and Health (2005–2019) on nearly 600,000 individuals, the study examined associations between various psychedelics and outcomes including depression, suicidal ideation, and psychological distress. While psychedelic use was associated with better mental health among non-Hispanic Whites, there were fewer such positive associations among Black, Hispanic, and Asian individuals, and just as many instances where use was linked to worse mental health, especially for Black and Asian groups.
Lifetime psychedelic use is not independently linked to lower odds of missing needed mental health treatment after accounting for psychological distress. However, among people with higher distress, those who have used psychedelics—especially men—show a smaller increase in missed care compared to non-users. For women, only MDMA use shows a similar buffering effect. The findings indicate that psychedelic exposure does not uniformly improve treatment engagement and that gender differences exist in how distress relates to disengagement from care. Structural inequality may produce diminished benefits for women despite similar distress levels.